Secure Genetics draws upon the expertise of its local and international Affiliates who are specialists in diverse fields of clinical medicine such as oncology and cardiology, pathology of normal and diseased tissues, renal research, brain structure and function, genetics, epigenetics and genomics, next-generation molecular technologies, commercial aspects of biotechnology and in the legal aspects of corporate enterprises.
We have provided independent advice on; the functional genomics of the Human and Mouse Genome Projects; the renal disease area; DNA methylation, adult stem cells, methylation and epigenetic-based microbial detection systems, pharmacogenomics of cardiovascular disease and personalized medicine, Alzheimer's disease and advanced diagnostic technologies.
George L Gabor Miklos, PhD
Director of Secure Genetics, Sydney, Australia
George Miklos holds a PhD in Genetics and has extensive laboratory experience in genetics, genomic manipulation and data analysis across diverse disciplines. He has held academic positions at Australian, European and US universities and institutions as well as a Fulbright Scholarship. He has been an invited speaker at diverse symposia including a Nobel Symposium. He has provided advice to international firms and individuals in the areas of molecular clinical information and advanced molecular technologies and been a reviewer of a number of research programs including those at the American Museum of Natural History and the New York Botanical Gardens. His publications and research activities cover a broad spectrum of scientific disciplines; eukaryote genomes in development and evolution; the complete genetic dissection of a eukaryote genome by segmental aneuploidy; complementation analysis of mitochondrial genomes in yeast; microarray analyses of schizophrenia; relaxation complexes in bacteria; genomic evolution and paleontological aspects of development in different phyla; molecules and cognition; the emergence of complexity in nervous systems and The Human Cancer Genome Project.
|
Phillip J Baird, MB BS PhD MHL Grad.Dipl.HML
Principal pathologist and CEO of Integrated Diagnostic Pathology, Sydney, Australia
Phillip Baird holds primary medical degrees, a PhD in the pathology of gynaecological cancer and legal degrees in health law. He has been a consultant in histopathology and cytopathology for several teaching hospitals and private pathology laboratories. He owned and operated a specialist diagnostic laboratory and has been a leading researcher into the aetiology and pathology of gynaecological cancers. He pioneered the introduction of Liquid Based Cytology for cervical samples. He has lectured at conferences throughout China, Korea, Singapore and the Phillipines. He has been an advisor to the Office of the Australian Prime Minister on cancer screening technologies.
|
 Dr Ian E Haines MBBS FRACP FAChPM
Melbourne Oncology Group, Cabrini Health and Honorary Senior Lecturer in the Department of Medicine, Monash University, Melbourne, Australia
Dr Haines is a practising medical oncologist in the Melbourne Oncology Group, Cabrini Health and Honorary Senior Lecturer in the Department of Medicine, Monash University, Melbourne, Australia. His interests are in providing the best available care for his patients and in the standards of treatment that either prolong overall survival, enhances the quality of life, improve cost effectiveness, or all three. He has extensive experience in evaluating the data from clinical trials and has been a leading advocate for the disclosure of conflicts of interest in medical research.
|
David Tarin, MD PhD
Professor of Pathology Moores/UCSD Comprehensive Cancer Center, La Jolla, California, USA
David Tarin previously served as Director of the UCSD Cancer Center with earlier appointments as Professor of Pathology at Oxford University in the United Kingdom and the Royal Postgraduate Medical School, Hammersmith Hospital, London, UK. His clinical specialty is in diagnostic surgical histopathology and autopsy pathology with special reference to breast, lung, cardiovascular system and cancer of all organs. He is actively involved in participation in multidisiplinary clinico-pathological meetings involved in patient care. David Tarin's Research interests are in the pathogenesis of cancer and mechanisms of cancer metastasis with special focus on interactions between normal and neoplastic cells and molecules involved.
|
 Giulio Tononi MD PhD
Professor of Psychiatry, School of Medicine, Department of Psychiatry, University of Wisconsin, Madison, Wisconsin, USA,
Giulio Tononi is a world expert in consciousness and its disorders and the mechanisms and functions of sleep. In addition, he has constructed computer models based on the anatomy and physiology of the thalamocortical system to study information integration in the brain. He has pioneered experimental approaches by using neuroimaging and transcranial magnetic stimulation. He is the author of a number of books including Universe of consciousness: how matter becomes imagination.
|
Chiara Cirelli MD PhD
Professor of Psychiatry, School of Medicine, University of Wisconsin, Madison, Wisconsin, USA.
Chiara Cirelli is an acknowledged world leader in the electrophysiology and molecular biology of sleep and sleep deprivation. Her work involves the analysis of transcriptomes in the brains of patients who have died of fatal familial insomnia and with spongiform degeneration. She is also an expert in the molecular genetics of sleep in model organisms such as Drosophila where she has performed large scale mutagenesis screening for individuals that need little sleep or for those that are resistant to sleep. She integrates whole-genome profiling and high density DNA microarray analyses with behavioural and EEG studies.
|
 Stephen May MB BS
Coffs Harbour Medical Centre
Australia
Stephen May has extensive experience in the Australian Healthcare system. He holds appointments as a GP (Family Physician), GP (Obstetrician) and GP (Anaesthetist) at the Coffs Harbour Public Health Campus and the Baringa Private Hospital.
|
 Alberto Ferrus PhD
Director of the Instituto Cajal, Madrid, Spain.
Alberto Ferrus is Director of Spains premier brain Institute. He is known internationally for his research work in the neurogenetics, electrophysiology and development of the brains of model organisms, with special skills in genomic manipulation, in brain wiring phenomena and in phenotypic disturbances and their underlying mechanisms. He is a classically trained geneticist with molecular expertise in transgenic organisms and the effects of gene mutations on phenotypic disturbances.
|
Andrzej Drukier PhD
President and CEO of BioTraces Inc. Herndon, Virginia, USA.
Andrzej Drukier is a physicist who has turned to clinical diagnostics. He holds a PhD in physics from the Niels Bohr Institute and the University of Copenhagen and is an inventor of Multi Photon Detection systems for the ultra sensitive diagnosis of breast and prostate cancer as well as the detection of ultra low levels of infectious agents.
|
